¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Slow Fe Iron Tablets"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • iron chelation
    öų·¹ÀÌÆ®È­
  • iron deficiency anemia
    ö°áÇ̺óÇ÷
  • iron liver
    °£Ã¶Áõ
  • iron metabolism
    ö´ë»ç
  • iron transport
    ö¿î¹Ý
  • iron-binding capacity
    ö°áÇÕ´É
  • iron-storage disease
    öÃàÀûÁúȯ
  • plasma iron
    Ç÷Àåö
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü
  • plasma iron turnover rate
    Ç÷Àåö±³Ã¼À²
  • red cell iron renewal rate
    ÀûÇ÷±¸Ã¶±³´ëÀ²
  • storage iron
    ˜ˌ̦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • triple sugar iron agar
    »ï´çö¿ì¹«
  • iron chelation
    öų·¹ÀÌÆ®È­
  • iron-binding capacity
    ö°áÇÕ´É
  • iron
    ö
  • iron liver
    °£Ã¶Áõ
  • iron binding protein
    ö°áÇմܹéÁú
  • iron-hematoxylin stained smear
    öÇ츶Åå½Ç¸°¿°»ö¹Ù¸¥Ç¥º»
  • plasma iron
    Ç÷Àåö
  • storage iron
    ˜ˌ̦
  • total red cell iron
    ¿ÂÀûÇ÷±¸Ã¶
  • wrought iron
    ¿¬Ã¶
  • marrow iron stain
    °ñ¼öö¿°»ö
  • plasma iron pool
    Ç÷ÀåöÀúÀå°í
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü
  • plasma iron turnover rate
    Ç÷Àåö±³Ã¼À²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü(úìíìôÑá¼ã÷ëÒ).
  • plasma iron pool
    Ç÷ÀåöÀúÀå°í.
  • plasma iron turnover
    Ç÷Àåö±³Ã¼
  • plasma iron turnover rate
    Ç÷Àåö±³Ã¼À².
  • red cell iron renewal rate
    ÀûÇ÷±¸Ã¶±³´ëÀ²(îåúìϹôÑÎßÓÛëÒ).
  • red cell iron turnover
    ÀûÇ÷±¸Ã¶±³´ë(îåúìϹôÑÎßÓÛ).
  • reduced iron ³ª ferrum reductum
    ȯ¿øÃ¶(ü½êªôÑ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • slow onset infection
    ¿Ï¼­½Ã¹ß°¨¿°, ¿Ï¼­¹ßº´°¨¿°(Áõ).
  • slow potential
    ¿Ï¼­ÀüÀ§.
  • slow pulse
    ´À¸°¸Æ, ¼­¸Æ(ßïØæ).
  • slow reacting substance
    Áö¿¬¹ÝÀÀ¼º ¹°Áú (òÀæÅÚãëëàõÚªòõ).
  • slow reacting substance of anaphylaxis
    ¾Æ³ªÇʶô½Ã½º Áö¿¬¹ÝÀÀ¹°Áú
  • slow respiration
    ´À¸°È£Èí(¡­û¼ýå).
  • slow sand filter
    ¿Ï¼Ó(ËíËÛ)¸ð·¡Ãþ°Å¸£±â.
  • slow ventricular filling phase
    ½É½Ç¿Ï¼Ó Ãæ¸¸±â.
  • slow virus
    Áö¹ß (òÀÛ¡) ¹ÙÀÌ·¯½º
  • slow virus
    ½½·Î¿ì¹ÙÀÌ·¯½º.
  • slow virus
    ½½·Î¿ì¹ÙÀÌ·¯½º.
  • slow virus
    ½½·Î¿ì¹ÙÀÌ·¯½º(¡­)
  • slow virus infection
    ½½·Î¿ì¹ÙÀÌ·¯½º°¨¿° (¡­Êïæø).
  • slow virus infection
    ½½·Î¿ì¹ÙÀÌ·¯½º°¨¿°(¡­Êïæø).
  • slow virus infection
    Áö¹ß (òÀÛ¡) ¹ÙÀÌ·¯½º °¨¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nonheme iron
    ºñ(Þª)Èûö(ôÑ)
  • nonheme-iron chromophore
    ºñ(Þª)Èû-ö(ôÑ) ¹ß»ö´Ü(Û¡ßäÓ¥)
  • nonheme-iron protein
    ºñ(Þª)Èû-ö(ôÑ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • total iron-binding capacity
    ÃÑö°áÇÕ´É (õÅôÑÌ¿ùêÒö)
  • unsaturated iron-binding capacity
    ºÒÆ÷È­(ÝÕøéûú) ö°áÇÕ´É(ôÑÌ¿ùêÒö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSUF continuous slow ultrafiltration
ERSP event-related slow potential
LSWA large amplitude slow wave activity
Psci pressure at slow component intercept
RDS Raskin Depression Scale; respiratory distress syndrome; reticuloendothelial depressing substance; rh...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SCP Slow Cortical Potential
SRS-A Slow Reacting Substance of Anaphylaxis
SR Slow Release
SVC Slow Vital Capacity
SW Slow Wave
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
slow virus disease A disease that follows a slow, progressive course spanning months to years, frequently involving the central nervous system, and ultimately leading to death, such as visna and maedi of sheep, caused by viruses of the subfamily Lentivirinae (family Retroviridae), and subacute sclerosing panencephalitis, seemingly caused by the measles virus; spongiform encephalopathies including kuru of man, scrapie of sheep, and transmissible encephalopathy of mink may also be classified under slow virus disease but their respective aetiologic agents have not been adequately characterised.
(05 Mar 2000)
slow virus diseases Diseases of viral origin, characterised by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. Though the disease process is protracted, viral multiplication may not be unusually slow. Conventional viruses produce slow virus diseases such as subacute sclerosing panencephalitis, progressive multifocal leukoencephalopathy (leukoencephalopathy, progressive multifocal), and aids. Diseases produced by unconventional agents were originally considered part of this group. They are now called prion diseases.
(12 Dec 1998)
albuminised iron Iron albuminate, a compound of iron oxide and albumin; rendered soluble by the presence of sodium citrate; occurs as reddish brown, lustrous granules, odourless or nearly so; used in anaemia.
(05 Mar 2000)
anaemia, iron deficiency Deficiency of iron results in anaemia because iron is necessary to make haemoglobin, the key molecule in red blood cells responsible for the transport of oxygen. In iron deficiency anaemia, the red cells are unusally small (microcytic) and pale (hypochromic). Characteristic features of iron deficiency anaemia in children include failure to thrive (grow) and increased infections. The treatment of iron deficiency anaemia, whether it be in children or adults, is with iron and iron-containing foods. Food sources of iron include meat, poultry, eggs, vegetables and cereals (especially those fortified with iron). According to the National Academy of Sciences, the Recommended Dietary Allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men.
Anaemia characterised by low or absent iron stores, low serum iron concentration, elevated free erythrocyte porphorin, low transferrin saturation, elevated transferrin, low serum ferritin, low haemoglobin concentration or haematocrit, and hypochromic microcytic red blood cells. Symptoms may include pallor, angular stomatitis and other oral lesions, gastrointestinal complaints, retinal haemorrhages and exudates, and thinning and brittleness of the nails. Among the causes of iron-deficiency anaemia are inadequate iron intake, impaired iron absorption, increased blood loss and increased requirements such as infancy, pregnancy, and lactation.
(12 Dec 1998)
brain iron <radiology> Normal, Infant: NONE, Adult: globus pallidum, substantia nigra, red nucleus, dentate nucleus, Aging: (adult) and putamen, Degenerative disease, Parkinson disease: putamen, SN compacta, Huntington disease: caudate, putamen, Alzheimer disease: cerebral cortex, Hallervorden-Spatz disease, MS: thalamus, putamen, Others, AVM: malformation and rim, Bleed: rim macrophages, Haemorrhagic CVA: gyral / basal ganglia MRI: low T1 and T2 signal
(12 Dec 1998)
peptonised iron A compound of iron oxide and peptone, rendered soluble by the presence of sodium citrate; used in the treatment of iron deficiency anaemia.
(05 Mar 2000)
molybdenum-iron protein aldehyde oxidoreductase <enzyme> Related to xanthine oxidase; isolated from desulfovibrio gigas
Registry number: EC 1.2.7.-
Synonym: mop protein
(26 Jun 1999)
Weigert's iron haematoxylin stain <technique> A nuclear staining solution containing haematoxylin, ferric chloride, and hydrochloric acid; useful in combination with von Gieson's stain, especially for demonstrating connective tissue elements or Entamoeba histolytica in sections.
(05 Mar 2000)
Mowry's colloidal iron stain <technique> A stain used for demonstrating acid mucopolysaccharides.
(05 Mar 2000)
Hale's colloidal iron stain <technique> A stain used to distinguish acid mucopolysaccharides such as hyaluronic acid; may be combined with PAS to also visualise carbohydrate-containing proteins and glycoproteins.
(05 Mar 2000)
Heidenhain's iron haematoxylin stain <technique> An iron alum haematoxylin stain used for staining muscle striations and mitotic structures blue-black.
(05 Mar 2000)
serum iron level A test that measures the amount of iron (Fe ++) in the blood. The test is performed when iron deficiency is suspected. Normal serum iron is 60 to 170 mcg/dl. Increased levels may be seen in the following: haemochromatosis, haemolysis, haemolytic anaemia, hepatitis, liver necrosis, haemosiderosis, iron poisoning and lead toxicity. Lower than normal levels are seen in chronic GI blood loss, iron deficiency anaemia, insufficient dietary iron, malabsorption, chronic heavy menstrual bleeding, nephrosis and late pregnancy.
(27 Sep 1997)
spiegel iron <chemistry> A fusible white cast iron containing a large amount of carbon (from three and a half to six per cent) and some manganese. When the manganese reaches twenty-five per cent and upwards it has a granular structure, and constitutes the alloy ferro manganese, largely used in the manufacture of Bessemer steel.
Synonym: specular pig iron, spiegel, and spiegeleisen.
Origin: G. Spiegel mirror + E. Iron.
Source: Websters Dictionary
(01 Mar 1998)
nickel-iron hydrogenase <enzyme> From desulfovibrio multispirans
Registry number: EC 1.12.-
Synonym: nife hydrogenase, co-induced hydrogenase, co-tolerant hydrogenase
(26 Jun 1999)
nickel-iron-selenium hydrogenase <enzyme> From desulfovibrio baculatus
Registry number: EC 1.12.-
Synonym: nifese hydrogenase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cramp iron
    ²ª¼è;°É¼è
  • curling iron
    Çì¾î ¾ÆÀ̾ð !
  • driving iron
    (°ñÇÁ)¾ÆÀ̾ð Ŭ·´ No.1
  • dumb iron
    (ÀÚµ¿Â÷ÀÇ)½ºÇÁ¸µ ¹Þħ
  • firing iron
    ³«Ã¶;¼Ò¶ôħ
  • foundry iron
    ÁÖö
  • galvanized iron
    ¾Æ¿¬ öÆÇ(¾çö)µî
  • grappling iron(hook)
    (Àû¼± µîÀ» °É¾î Àâ¾Æ´ç±â´Â)¼è°¥°í¸®
  • hoop iron
    (Åë µîÀÇ) ¼èÅ×
  • iron
    ¼èÀÇ;¼è °°Àº;öÁ¦ÀÇ;°ß°íÇÑ;³ÃȤÇÑ
  • iron
    ö;¼è(±Ý¼Ó¿ø¼Ò);öÁ¦ ±â±¸;¾ÆÀ̾ð;´Ù¸®¹Ì;ÀεÎ;(°ñÇÁ)¼è¸Ó¸®°¡ ´Ù¸° °ñÇÁä;µîÀÚ;Á·¼â;¼ö°©;´Ù¸®±³Á¤±â;öÁ¦;öºÐ;ÀÚµ¿Â÷;±ÇÃÑ;ÃÑ;ÀÛ»ì;ÀºÈ­
  • iron
    ´Ù¸²ÁúÇÏ´Ù;...¿¡ ¼ö°©À»(Â÷²¿¸¦) ä¿ì´Ù;¼è·Î µ¤¾î ½Î´Ù;Àå°©ÇÏ´Ù
  • iron age
    ö±â½Ã´ë;(±×½Å)ÈæÃ¶½Ã´ë(golden,age,silver age,bronze age¿¡ °è¼ÓµÇ´Â °¡Àå Ÿ¶ôÇß´ø ½Ã´ë)
  • iron crutain
    öÀÇ À帷(¼Ò·ÃÃø°ú ¼­¹æÃøÀ» °¥¶ó ³õ´Â Á¤Ä¡Àû »ç»óÀû º®(cf.BAMBOO CURTAIN
  • iron founder
    ÁÖö Á¦Á¶¾÷ÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á